Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 4696 (MIR4696) is a member of the microRNA (miRNA) family, which are small (typically 20–24 nucleotides), endogenous non-coding RNAs that regulate gene expression primarily at the post-transcriptional level in multicellular organisms[4][8]. Like other miRNAs, MIR4696 is presumed to function by binding to complementary sequences in target messenger RNAs (mRNAs), resulting in translational repression or target degradation and gene silencing[1][3]. However, there is no strong evidence or specific literature linking microRNA 4696 to well-defined biological functions, disease associations, or therapeutic targeting. As such, it is not considered a therapeutic target nor associated with clinical biomarkers, interacting drugs, or safety concerns. The entry for MIR4696 in widely used gene databases confirms its existence as a miRNA gene, but detailed characterization, validated biological roles, or disease relevance have not been established[4]. Additional Notes: - There is no significant evidence MIR4696 is "considered a therapeutic target" (such as a receptor, enzyme, or transporter, or with evidence of druggability or clinical utility)[4]; miRNAs in general regulate biological pathways but only a few have direct therapeutic engagement in oncology, virology, or other contexts[8]. - No peer-reviewed references or curated data assign MIR4696 a specific function or disease association at this time, and there are no known small molecule or oligonucleotide drugs targeting this specific miRNA. - Its general classification as a post-transcriptional regulator is based on the broader role of miRNAs, not on target-specific data. - If your intended use is for target identification in drug discovery, MIR4696 should not currently be considered a validated or relevant therapeutic target. - The search revealed some redundancy and lack of confirmatory detail in individual database listings, suggesting that information is sparse and largely uncharacterized—hence, "is_incorrect" is set to true, as this target currently lacks adequate supporting information for most structured use cases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 4696 (MIR4696).